A key challenge for regulators including the HRA, and maybe the health care Local community as a whole, is to know when and how to re-look at very long standing thoughts or dogmas. Precisely when should really anecdotal evidence from sometimes incredibly vocal affected person teams be examined in time consuming and high-priced clinical trials?We pr